SCHEMBL6409153

SCHEMBL6409153

CCOC(=O)NC(CCN1CCC2(CC1)CCN(Cc1ccc(OC)cc1)C2=O)c1cccc(Cl)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.42
KMT2A Q03164 7/20 0.42
ROCK2 O75116 1/20 0.41
ROCK1 Q13464 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
ALDH1A1 P00352 1/20 0.39
CCR5 P51681 1/20 0.39
MAPK1 P28482 1/20 0.38
POLB P06746 2/20 0.38
CACNA1G O43497 1/20 0.38
LMNA P02545 3/20 0.37
DRD4 P21917 1/20 0.37
KCNH2 Q12809 1/20 0.37
THRB P10828 1/20 0.37
RECQL P46063 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MMP1 P03956 1/20 0.37
MMP9 P14780 1/20 0.37
MMP13 P45452 1/20 0.37
ADAM17 P78536 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6409150 0.99 MEN1 (0.41) MEN1KMT2AROCK2ROCK1L3MBTL1
SCHEMBL6411551 0.95 ROCK2 (0.44) MEN1KMT2AROCK2ROCK1L3MBTL1
Hydrochloric Acid SCHEMBL6411547 0.94 ROCK2 (0.44) MEN1KMT2AROCK2ROCK1L3MBTL1
SCHEMBL6414554 0.94 ROCK2 (0.42) MEN1KMT2AROCK2ROCK1ALDH1A1
Hydrochloric Acid SCHEMBL6414551 0.93 ROCK2 (0.42) MEN1KMT2AROCK2ROCK1ALDH1A1
SCHEMBL6410286 0.92 HDAC11 (0.38) MEN1KMT2AROCK2ROCK1L3MBTL1
Hydrochloric Acid SCHEMBL6410281 0.91 HDAC11 (0.37) MEN1KMT2AROCK2ROCK1ALDH1A1
SCHEMBL6415469 0.91 UTS2R (0.42) MEN1KMT2AL3MBTL1ALDH1A1CCR5
SCHEMBL6414737 0.90 CCR5 (0.41) MEN1KMT2AL3MBTL1ALDH1A1CCR5
SCHEMBL6409348 0.90 ROCK2 (0.40) MEN1KMT2AROCK2ROCK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050075326-A1 Spiro compounds and methods for the modulation of chemokine receptor activity VIROCHEM PHARMA INC (CA) 2005-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075326-A1 Spiro compounds and methods for the modulation of chemokine receptor activity CXCR1, CXCR4, CXCR2 MEN1 4007/4885KMT2A 4587/4885ROCK2 1735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.